KYMR
Kymera Therapeutics Inc.
$51.01
+$1.88(+3.83%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$3.51B
Volume
730.91K
52W Range
$19.45 - $53.27
Target Price
$63.05
EPS Estimates Overview
| Current Quarter | $-0.73 | Next Quarter | $-0.85 |
| Current Year | $-3.29 | Next Year | $-3.89 |
| QoQ Growth | -16.4% | YoY Growth | -18.2% |
| 3Y EPS CAGR | -12.6% | Target Price | $63.05 |
| Consensus | Buy | Upside | +23.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $51.01 | +3.8% | 730.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW